Combined Vitrectomy and Femtosecond Laser-assisted Cataract Surgery
Macular Disease, Rhegmatogenous Retinal Detachment, Epiretinal Membrane
About this trial
This is an interventional treatment trial for Macular Disease
Eligibility Criteria
Inclusion Criteria: clinical diagnosis of following disease
- RRD with cataract
- ERM with cataract
- MH with cataract
- Vitreous opacity with cataract
Exclusion Criteria: patients with history of following condition
- intraocular surgery
- ocular trauma
- endophthalmitis
- uveitis
- glaucoma
Sites / Locations
- Jiasong YangRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
Experimental
Experimental
RRD group
ERM group
MH group
Vitreous cloudy group
to evaluate the efficacy and complications of a new minimally invasive vitreoretinal surgery combined with FLACS in the treatment of rhegmatogenous retinal detachment complicated with cataract.
to evaluate the efficacy and complications of a new minimally invasive vitreoretinal surgery combined with FLACS in the treatment of epiretinal membrane complicated with cataract.
to evaluate the efficacy and complications of a new minimally invasive vitreoretinal surgery combined with FLACS in the treatment of macular hole complicated with cataract.
to evaluate the efficacy and complications of a new minimally invasive vitreoretinal surgery combined with FLACS in the treatment of vitreous opacity complicated with cataract.